Read More Pharma Industry News Sanofi and Regeneron’s Dupixent shows promising results in Phase 3 eczema trial Sanofi and Regeneron Pharmaceuticals have achieved a significant milestone with their jointly developed eczema drug, Dupixent (dupilumab), meeting… bypharmanewsdailyMarch 5, 2017
